Skip to main content
Premium Trial:

Request an Annual Quote

PGXL Labs, Essential Molecular Testing Ink National Distribution Deal

NEW YORK (GenomeWeb News) – Pharmacogenetic testing firm PGXL Laboratories announced on Thursday a long-term national distribution deal with Essential Molecular Testing for PGXL's drug sensitivity testing.

The partnership, called PGXL Partners, provides the Louisville, Ky.-based laboratory a larger sales force to address growing demand for its tests. In a statement, PGXL Labs President Roland Valdes Jr., said that the company has increased sales of its tests to thousands each month from hundreds.

The partnership between the two companies "began to take shape" in May and by the end of the year, more than 50,000 pharmacogenetic tests will have been ordered through PGXL Partners, PGXL Labs said. Its pharmacogenetic test menu includes CYP2C19, KRAS mutation detection, NAT2, and hepatitis B virus DNA quantitative assays.

Financial and other terms of the deal were not disclosed.

In August PGXL Labs and SureGene partnered to launch a five-gene test for determining which patients may be best candidates for the most widely used antipsychotics and antidepressants.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.